BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2418939)

  • 1. Flow cytometric analysis of tumor antigen TA-4 in cervical cytologic specimens.
    Suehiro Y; Kato H; Nagai M; Torigoe T
    Cancer; 1986 Apr; 57(7):1380-4. PubMed ID: 2418939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric analysis of tumor antigen TA-4 in cervical squamous cells.
    Sasaki K; Nagai M; Kato H; Torigoe T; Nagamine Y; Takahashi M
    Gan; 1984 Aug; 75(8):703-6. PubMed ID: 6386588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneous distribution of acidic TA-4 in cervical squamous cell carcinoma: immunohistochemical demonstration with monoclonal antibodies.
    Kato H; Suehiro Y; Morioka H; Torigoe T; Myoga A; Sekiguchi K; Ikeda I
    Jpn J Cancer Res; 1987 Nov; 78(11):1246-50. PubMed ID: 3121560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tumor antigen TA-4 of squamous cell carcinoma in patients with cervical cancer].
    Kato H; Morioka H; Aramaki S; Tamai K; Nagaya T; Nagai M; Torigoe T
    Gan No Rinsho; 1984 May; 30(6 Suppl):574-7. PubMed ID: 6748228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical carcinoma antigen, carcinoembryonic antigen (CEA), and nonspecific cross-reacting antigen (NCA) in appraisal of uterine cervix smears.
    Harlozinska A; Kula J; Stepinska B; Jelen M; Richter R; Slesak B
    Am J Clin Pathol; 1985 Mar; 83(3):301-7. PubMed ID: 3883744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunocytochemical staining of cervical smears for the diagnosis of cervical intraepithelial neoplasia.
    Moncrieff D; Ormerod MG; Coleman DV
    Anal Quant Cytol; 1984 Sep; 6(3):201-5. PubMed ID: 6391321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of a tumor antigen TA-4 of squamous cell carcinoma in relation to its appearance in the circulation.
    Kato H; Nagaya T; Torigoe T
    Gan; 1984 May; 75(5):433-5. PubMed ID: 6745563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-associated antigen, TA-4, in the monitoring of the effects of therapy for squamous cell carcinoma of the uterine cervix. Serial determinations and tissue localization.
    Maruo T; Shibata K; Kimura A; Hoshina M; Mochizuki M
    Cancer; 1985 Jul; 56(2):302-8. PubMed ID: 2408732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of squamous cell carcinoma antigen in normal squamous epithelia and in squamous cell carcinomas of the uterine cervix.
    Crombach G; Scharl A; Vierbuchen M; Würz H; Bolte A
    Cancer; 1989 Apr; 63(7):1337-42. PubMed ID: 2920361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the special tumor marker of cervical cancer of the uterus.
    Kato H
    Semin Surg Oncol; 1987; 3(1):55-63. PubMed ID: 3544141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunomorphological studies of the antigen associated with squamous cell cancer of the human cervix uteri].
    Ievleva ES; Marshutina NV; Ageenko AN; Khmel'nitskaia NG
    Biull Eksp Biol Med; 1992 Mar; 113(3):304-6. PubMed ID: 1421235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Flow cytofluorometric analysis for screening cervical squamous cell carcinoma using specific antibody to a tumor antigen TA-4].
    Nagai M
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Apr; 36(4):612-6. PubMed ID: 6715941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioimmunoassay for tumor-antigen of human cervical squamous cell carcinoma.
    Kato H; Morioka H; Aramaki S; Torigoe T
    Cell Mol Biol Incl Cyto Enzymol; 1979; 25(1):51-6. PubMed ID: 533610
    [No Abstract]   [Full Text] [Related]  

  • 14. Value of tumor-antigen (TA-4) of squamous cell carcinoma in predicting the extent of cervical cancer.
    Kato H; Morioka H; Tsutsui H; Aramaki S; Torigoe T
    Cancer; 1982 Oct; 50(7):1294-6. PubMed ID: 7104971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunohistological evaluation of the cancer associate antigen (TA-4) for pathoclinical management of the cervical malignancy].
    Kimura A; Shibata K; Hoshina M; Maruo T; Mochizuki M
    Nihon Gan Chiryo Gakkai Shi; 1984 Dec; 19(10):2248-54. PubMed ID: 6533207
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical significance of tumor associated antigen TA-4 in gynecologic tumors].
    Inoue Y; Ueda G; Yamasaki M; Inoue M; Tanaka Y; Hiramatsu K; Nishino T; Saito J; Abe Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jun; 37(6):919-22. PubMed ID: 3894536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunomorphological identification of an antigen associated with squamous cell carcinoma of the cervix uteri].
    Ievleva ES; Ermoshina NV; Ageenko AI
    Eksp Onkol; 1988; 10(5):33-5. PubMed ID: 3061778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoperoxidase staining of cervicovaginal smears after radiotherapy.
    Wachtel MS; Thaler HT; Gangi MD; Hajdu SI
    Acta Cytol; 1992; 36(3):305-9. PubMed ID: 1580112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-associated antigen 22-1-1 expression in the uterine cervical squamous neoplasias.
    Sonoda K; Kaku T; Kamura T; Nakashima M; Watanabe T; Nakano H
    Clin Cancer Res; 1998 Jun; 4(6):1517-20. PubMed ID: 9626471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-antigen TA-4 in the detection of recurrence in cervical squamous cell carcinoma.
    Kato H; Tamai K; Morioka H; Nagai M; Nagaya T; Torigoe T
    Cancer; 1984 Oct; 54(8):1544-6. PubMed ID: 6478396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.